Archive for the
‘DnXT Reviewer’ Category

Introduction: In the realm of pharmaceutical regulatory affairs, the electronic Common Technical Document (eCTD) has transformed the way drug submissions are prepared and reviewed. eCTD submissions encompass a myriad of information critical for regulatory decision-making, making the review process a complex and meticulous task. To simplify and streamline this endeavor, regulatory agencies and industry professionals […]

May 14, 2021

dnxtuser

DnXT Reviewer